Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil

Oncogene
H M R RobinsonD A F Gillespie

Abstract

Chk1 plays a crucial role in the DNA damage and replication checkpoints in vertebrates and may therefore be an important determinant of tumour cell responses to genotoxic anticancer drugs. To evaluate this concept we compared the effects of the nucleoside analogue 5-fluorouracil (5FU) on cell cycle progression and clonogenic survival in DT40 B-lymphoma cells with an isogenic mutant derivative in which Chk1 function was ablated by gene targeting. We show that 5FU activates Chk1 in wild-type DT40 cells and that 5FU-treated cells accumulate in the S phase of the cell cycle due to slowing of the overall rate of DNA replication. In marked contrast, Chk1-deficient DT40 cells fail to slow DNA replication upon initial exposure to 5FU, despite equivalent inhibition of the target enzyme thymidylate synthase, and instead accumulate progressively in the G1 phase of the following cell cycle. This G1 accumulation cannot be reversed rapidly by exogenous thymidine or removal of 5FU, and is associated with increased incorporation of 5FU into genomic DNA and severely diminished clonogenic survival. Taken together, these results demonstrate that a Chk1-dependent replication checkpoint which slows S phase progression can protect tumour cells again...Continue Reading

References

Dec 15, 1980·Experientia·J P Friend, M T Tseng
Jul 1, 1981·The British Journal of Surgery·D A Lloyd
Jan 1, 1980·Journal of Cancer Research and Clinical Oncology·T SaitoK Inokuchi
Feb 22, 2000·The Journal of Biological Chemistry·P R GravesH Piwnica-Worms
Jun 8, 2001·Molecular and Cellular Biology·H Zhao, H Piwnica-Worms
Aug 17, 2001·Environmental Science & Technology·G M FilzJ C Little
Sep 7, 2001·Genes & Development·R T Abraham
Nov 14, 2002·Annual Review of Genetics·Kara A NybergTed A Weinert
Jan 30, 2003·The EMBO Journal·George ZachosDavid A F Gillespie
May 2, 2003·Nature Reviews. Cancer·Daniel B LongleyPatrick G Johnston
Jun 5, 2003·Cancer Cell·Jiri Bartek, Jiri Lukas
Jun 7, 2003·Science·Lee Zou, Stephen J Elledge
Dec 10, 2003·Oncogene·Deepa SampathWilliam Plunkett
Nov 19, 2004·Nature·Michael B Kastan, Jiri Bartek
Dec 22, 2004·The Journal of Biological Chemistry·Mark MeyersDavid A Boothman
Jan 6, 2005·Molecular and Cellular Biology·George ZachosDavid A F Gillespie
Aug 3, 2005·Cancer Research·Meredith A MorganTheodore S Lawrence

❮ Previous
Next ❯

Citations

Nov 4, 2008·Cellular and Molecular Life Sciences : CMLS·M D Wyatt, D M Wilson
Dec 14, 2007·Cancer Chemotherapy and Pharmacology·Kei IjichiKanji Ishizaki
Oct 29, 2008·Oncogene·B EwaldW Plunkett
Jan 25, 2011·Oncogene·N Sangster-GuityF Bunz
Jun 23, 2009·The Journal of Biological Chemistry·Kideok JinEileen Friedman
Aug 4, 2010·The Journal of Cell Biology·Naihan XuDavid A Gillespie
Jan 10, 2012·Biochemical Pharmacology·Zhengguan YangMichael D Wyatt
Dec 23, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laura TaddiaMaria Paola Costi
Jul 5, 2008·Biochemical Pharmacology·Sondra H BergerMichael D Wyatt
Apr 19, 2013·British Journal of Clinical Pharmacology·Ruth Thompson, Alan Eastman
Feb 20, 2015·Cell Cycle·Léonard Jagot-LacoussiereJean-Luc Poyet
Sep 9, 2008·Biochemical Pharmacology·Zhengguan YangMichael D Wyatt
Nov 7, 2007·Analytical and Bioanalytical Chemistry·Mikiya SudaTakato Noumi
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monica GanzinelliGiovanna Damia

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.